Brief Article
Copyright ©2014 Baishideng Publishing Group Co.
World J Radiol. Mar 28, 2014; 6(3): 48-55
Published online Mar 28, 2014. doi: 10.4329/wjr.v6.i3.48
Table 2 Characteristics of excluded studies
Ref.YearCountryTumors(histology)Reason for exclusion
Bongers et al[7]2002NetherlandsNeck (laryngeal cancer)Cost study
van Hooren et al[8]2009NetherlandsNeck (laryngeal carcinoma)Cost study
Uly-de Groot et al[9]2010NetherlandsHead/neck (metastases)Cost study
Kurien et al[10]2011United StatesHead/neck (various)Cost study
Schergerin et al[11]2009United StatesBreast (various)No PET comparison
Auguste et al[12]2011United KingdomBreast (various)Review
Cooper et al[13]2011United KingdomBreast (various)Review
Strobel et al[14]2007SwitzerlandLymphoma (various)Cost study
Moulin-Romsee et al[15]2008BelgiumLymphoma (NHL)Cost study
Brush et al[16]2011United KingdomColon-rectum (various)Review
von Schulthess et al[17]1998SwitzerlandMelanoma (various)Cost study
Bastiaannet et al[18]2012NetherlandsMelanoma (various)Cost study
Heinzel et al[19]2012GermanyBrain (glioma)Aminoacid PET
Heinzel et al[20]2012GermanyBrain (glioma)Aminoacid PET
Hetzel et al[21]2003GermanyBone (metastases)F18-Fluoride PET
Tateishi et al[22]2010JapanBone (metastases)F18-Fluoride PET
Heinrich et al[23]2005AustriaPancreas (various)Cost study
Rondina et al[24]2012United StatesOccult (various)Cost study